title: Experience with 5FU + L-leucovorin.
authors.affiliation: Princess Margaret Hospital, Toronto, Canada.
authors.forename: C
authors.initials: C
authors.lastname: Erlichman
authors.forename: S
authors.initials: S
authors.lastname: Fine
authors.forename: I
authors.initials: I
authors.lastname: Kerr
authors.forename: W
authors.initials: W
authors.lastname: Hoffman
authors.forename: C
authors.initials: C
authors.lastname: Gorg
authors.forename: H J
authors.initials: HJ
authors.lastname: Schmoll
authors.forename: P
authors.initials: P
authors.lastname: Preusser
authors.forename: H J
authors.initials: HJ
authors.lastname: Senn
authors.forename: B
authors.initials: B
authors.lastname: Gustavsson
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D002955:Leucovorin / Q000008:administration & dosage
chemical_list: D002955:Leucovorin; D005472:Fluorouracil